Association between the IL28B genotype and hepatitis C viral kinetics in the early days of treatment with pegylated interferon plus ribavirin in HIV/HCV co-infected patients with genotype 1 or 4 | Zendy

Antonio RiveroJuárez | Zendy; Ángela Camacho Espejo | Zendy; Inés PérezCamacho | Zendy; Karin Neukam | Zendy; Antonio Carúz | Zendy; J. A. Mira | Zendy; Pilar Mesa | Zendy; Milagros García-Lázaro | Zendy; José Miguel Cisneros | Zendy; Juan A. Pineda | Zendy; Antonio Rivero | Zendy

Open Access

Association between the IL28B genotype and hepatitis C viral kinetics in the early days of treatment with pegylated interferon plus ribavirin in HIV/HCV co-infected patients with genotype 1 or 4

Author(s) -

Antonio RiveroJuárez,

Ángela Camacho Espejo,

Inés PérezCamacho,

Karin Neukam,

Antonio Carúz,

J. A. Mira,

Pilar Mesa,

Milagros García-Lázaro,

José Miguel Cisneros,

Juan A. Pineda,

Antonio Rivero

Publication year - 2011

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkr439

Subject(s) - ribavirin , pegylated interferon , genotype , virology , hepatitis c , hepatitis c virus , hepacivirus , human immunodeficiency virus (hiv) , medicine , interferon , biology , viral disease , virus , gene , genetics

To evaluate the effect of the interleukin 28B (IL-28B) genotype on hepatitis C virus (HCV) viral kinetics in the first 4 weeks from start of treatment with pegylated interferon plus ribavirin (PEG-IFN/RBV) in HIV/HCV co-infected patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research